Prolonged effects of dexamethasone following total knee arthroplasty: A pre‐planned sub‐study of the DEX‐2‐TKA trial
Open Access
- 14 September 2023
- journal article
- research article
- Published by Wiley in Acta Anaesthesiologica Scandinavica
- Vol. 68 (1) , 35-42
Abstract
Objectives: The DEX‐2‐TKA trial demonstrated that one and two doses of 24 mg intravenous dexamethasone reduced opioid consumption and pain after total knee arthroplasty (TKA). We aimed to investigate the prolonged effects of dexamethasone after the 48‐h intervention period.Design: This was a prospective, pre‐planned questionnaire follow‐up on postoperative days 3–7 of patients in the DEX‐2‐TKA trial that randomly received: DX1 (dexamethasone 24 mg + placebo), DX2 (dexamethasone 24 mg + dexamethasone 24 mg), and placebo (placebo + placebo) perioperatively and 24 h later.Setting: A multicenter trial performed at five Danish hospitals.Participants: We analyzed 434 of 485 adult participants enrolled in the DEX‐2‐TKA trial.Outcome Measures: Primary outcome was difference between groups in average of all numerical rating scale (NRS) pain scores reported in the morning, at bedtime, and the daily average pain on postoperative days 3–7. Secondary outcomes were sleep quality and patient satisfaction.Results: The median (interquartile range) pain intensity levels for postoperative days 3–7 were: DX2 3.2 (2.1–4.3); DX1 3.3 (2.3–4.1); and placebo 3.3 (2.5–4.7). Hodges–Lehmann median differences between groups were: 0 (95% confidence interval − 0.54 to 0.2), P = 0.38 between DX1 and placebo; 0.1 (−0.47 to 0.33), p = .87 between DX1 and DX2; and 0.1 (−0.6 to 0.13), p = .20 between DX2 and placebo. We found no relevant differences between groups on sleep quality on postoperative days 3–7 nor for patient satisfaction with the analgesic treatment.Conclusions: We found that neither one nor two doses of 24 mg intravenous dexamethasone demonstrated prolonged effects on overall pain or sleep quality on postoperative days 3–7 after total knee arthroplasty. We also found that dexamethasone had no effect on patient satisfaction.Trial registration number: Clinicaltrials.gov NCT03506789 (main result trial).Keywords
This publication has 17 references indexed in Scilit:
- Safety aspects of preoperative high-dose glucocorticoid in primary total knee replacementBritish Journal of Anaesthesia, 2017
- Long‐term outcomes and cost effectiveness of high‐dose dexamethasone for cardiac surgery: a randomised trialAnaesthesia, 2017
- Postoperative pain treatment after total knee arthroplasty: A systematic reviewPLOS ONE, 2017
- Principled missing data methods for researchersSpringerPlus, 2013
- Influence of Reported Study Design Characteristics on Intervention Effect Estimates From Randomized, Controlled TrialsAnnals of Internal Medicine, 2012
- International survey of primary and revision total knee replacementInternational Orthopaedics, 2011
- Effect of high-dose preoperative methylprednisolone on pain and recovery after total knee arthroplasty: a randomized, placebo-controlled trialBritish Journal of Anaesthesia, 2010
- The Prolonged Postoperative Analgesic Effect When Dexamethasone Is Added to a Nonsteroidal Antiinflammatory Drug (Rofecoxib) Before Breast SurgeryAnesthesia & Analgesia, 2007
- Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapyBritish Journal of Cancer, 2006
- Perioperative Single-Dose Glucocorticoid Administration: Pathophysiologic Effects and Clinical ImplicationsJournal of the American College of Surgeons, 2002